Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Successful phase II results for solithromycin in community-acquired bacterial pneumonia

May 26, 2016

FDA grants fast track status to Novavax's RSV F vaccine

May 26, 2016

Seed funding for Global Antibiotic Research and Development partnership

May 26, 2016

FDA approves Flucelvax Quadrivalent

May 25, 2016

Survival benefit with Pentaglobin in severe infections caused by multidrug-resistant bacteria

May 24, 2016

Positive topline results from a first-in-human trial of broad spectrum MVA-BN RSV vaccine

May 24, 2016

Enanta Pharmaceuticals patents antihepatitis agents

May 20, 2016

PfSPZ Vaccine provides durable protection against malaria

May 19, 2016

Novel experimental mouse models of Brazilian Zika virus infection

May 19, 2016

Redx Pharma describes antibacterial agents

May 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...